Officer and Director Stock Sale

Brian Daniel Webster, President and Chief Executive Officer of KESTRA MEDICAL TECHNOLOGIES, LTD., reported a series of non-discretionary sales of Common Shares. These sales, totaling 7,857 shares on July 30, 2026, 8,948 shares on July 31, 2026, and 13,017 shares on August 3, 2026, were conducted to cover tax withholding obligations associated with the vesting and settlement of restricted stock units. The sales occurred at weighted average prices ranging from $22.2524 to $23.1700 on July 30, $22.0577 to $22.9200 on July 31, and $23.6400 to $24.1100 on August 3. Following these transactions, Mr. Webster’s direct ownership of KESTRA MEDICAL TECHNOLOGIES, LTD. shares decreased, with post-transaction holdings reported at 549,080 shares after July 30, 540,132 shares after July 31, and 527,115 shares after August 3.